FG
NARI

Formula Growth’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Formula Growth’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-54,350
Closed -$2.62M – 128
2024
Q2 		$2.62M Buy
+54,350
New +$2.41M 0.95% 39

Other funds holding NARI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Formula Growth's NARI Position: Q3 2024 in Review

Formula Growth sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2024, closing a stake of 54,350 shares — an estimated $2.62M sold.

Formula Growth first reported a position in NARI in Q2 2024 and held it in 1 quarter. The position peaked at $2.62M in Q2 2024. 243 funds tracked by Wall St. Rank hold NARI as of Q3 2024.

  • Formula Growth reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Formula Growth sold 54,350 Inari Medical, Inc. Common Stock shares in Q3 2024, an estimated $2.62M.
  • Formula Growth first reported a position in Inari Medical, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Formula Growth's Inari Medical, Inc. Common Stock position peaked at $2.62M in Q2 2024.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2024.

Based on Formula Growth's 13F filing for Q3 2024, filed 13 Nov 2024.